Real-World Experience With Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients With HCV Genotype 2 Infection: A Multicenter, Retrospective Study
figure
posted on 2021-03-15, 11:57 authored by Adis journals on behalf of, Bo-Huang Liou, Hsin-Yun Sun, Chia-Jui Yang, Ling-Shan Syue, Yu-Lin Lee, Hung-Jen Tang, Hung-Chin Tsai, Chi-Ying Lin, Tun-Chieh Chen, Chun-Yuan Lee, Sung-Hsi Huang, Chia-Wei Liu, Po-Liang Lu, Shih-Ping Lin, Ning-Chi Wang, Aristine Cheng, Wen-Chien Ko, Shu-Hsing Cheng, Chien-Ching Hung on behalf on the Taiwan HIV Study Group<div><strong>Article full text</strong></div><div><br></div><div>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </div><div>© The authors, CC-BY-NC 2021. </div>
